Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds

Cancer immunotherapy and the emergence of immune checkpoint inhibitors have markedly changed the treatment paradigm for many cancers. They function to disrupt cancer cell evasion of the immune response and activate sustained anti-tumor immunity. Oncolytic viruses have also emerged as an additional t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivanandam, Venkatesh, LaRocca, Christopher J., Chen, Nanhai G., Fong, Yuman, Warner, Susanne G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503136/
https://www.ncbi.nlm.nih.gov/pubmed/31080879
http://dx.doi.org/10.1016/j.omto.2019.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503136/
https://www.ncbi.nlm.nih.gov/pubmed/31080879
http://dx.doi.org/10.1016/j.omto.2019.04.003

Ejemplares similares